Work

A phase II study of ribociclib in men with unresectable, incurable teratoma with recent progression.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.7_suppl.517

Authors: Daniel E. Castellano, David I. Quinn, Darren R. Feldman, Karim Fizazi, Xavier Garcia del Muro, Jourik A. Gietema, Richard C. Lauer, Mary Elizabeth Ising, Mehreteab Aregay, Adam Samuel Crystal, David J. Vaughn

Institutions: Hospital Universitario 12 De Octubre, University of Southern California, USC Norris Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Université Paris-Sud, Institut Gustave Roussy, Institut Català d'Oncologia, University Medical Center Groningen, UNM Comprehensive Cancer Center, Abramson Cancer Center, University of Pennsylvania

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2920809602

Cites:

Cited by: 8

Related to: 10